Polyrizon PLRZ
NASDAQ PLRZ
$10.30 -0.19 (-1.81%)
As of: Aug 21, 2026 · 3:34 PM EDT

Polyrizon (PLRZ) Prepaid Assets (2023 - 2025)

Polyrizon's (PLRZ) quarterly Prepaid Assets came in at $396000.0 in Q4 2025, up 300.0% YoY from $99000.0 in Q4 2024, and up 94.12% on a QoQ basis from $204000.0 in Q2 2025.

Polyrizon (PLRZ) Prepaid Assets (2023 - 2025) Analysis & Trends

Polyrizon (PLRZ) has 3 years of Prepaid Assets data on file, last reported at $396000.0 in Q4 2025.

  • Quarterly Prepaid Assets rose 300.0% year-over-year to $396000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $396000.0 (up 300.0% YoY) and the FY2025 annual result came in at $396000.0, up 300.0% from the prior year.
  • Prepaid Assets grew to $396000.0 in Q4 2025, from $204000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $396000.0 in Q4 2025 to a low of $13000.0 in Q4 2023.
  • A 3-year average of $178000.0 and a median of $151500.0 in 2024 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets surged 661.54% — and 2025, when it jumped 300.0%.
  • Tracing PLRZ's Prepaid Assets over 3 years: stood at $13000.0 in 2023, then surged by 661.54% to $99000.0 in 2024, then jumped by 300.0% to $396000.0 in 2025.
  • The last three Prepaid Assets figures came in at $396000.0 (Q4 2025), $204000.0 (Q2 2025), and $99000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Polyrizon 7.27 Mn -4.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 396,000.00
Jun 30, 2025 204,000.00
Dec 31, 2024 99,000.00
Dec 31, 2023 13,000.00